With a growing number of startups and established companies wanting a presence in Philly, the city has buzz. Here’s what’s behind it.
Over the last several years, no life sciences market in America has had greater momentum than Philadelphia. As the birthplace of cell and gene therapy, the city is not only producing breakout companies — including Spark Therapeutics (owned by Roche) and Tmunity Therapeutics (recently acquired by Kite) — it’s also become a place where both new and established…
